Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001902368-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 5, 2026 |
| Document Date | Feb 4, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
1,779
Total Value
$57,295.37
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Common Stock | โ | Feb 4, 2026 | Sale | 1,547 | $32.11 | $49,674.17 | 105,938 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Feb 4, 2026 | Sale | 232 | $32.85 | $7,621.20 | 105,706 | Direct | โ | View Details |